{"@odata.context":"https://open.ejn.gov.ba/$metadata#Procedures","value":[{"Id":2109565,"Announced":"2021-07-30T09:30:44.673Z","AwardCriterion":"LowestPrice","AwardType":"Contract","ContractingAuthorityId":47196,"ContractingAuthorityName":"ZAVOD ZDRAVSTVENOG OSIGURANJA I REOSIGURANJA FEDERACIJE BOSNE I HERCEGOVINE","ContractingAuthorityTaxNumber":"4200642000008","ContractingAuthorityCityName":"NOVO SARAJEVO","ContractingAuthorityType":"PublicEntity","ContractingAuthorityActivityTypeName":"Zdravstvo","ContractingAuthorityAdministrativeUnitType":"Entity","ContractingAuthorityAdministrativeUnitName":"Federacija Bosne i Hercegovine","ContractType":"Goods","HasComplaint":false,"HasLots":true,"IsAuctionOnline":false,"IsElectronicOffer":false,"IsJointProcurement":false,"IsMasterAgreement":false,"IsOnBehalfProcurement":false,"Name":"Nabavka lijekova INN okrelizumab inf. 300 mg, INN vemurafenib tbl. 240 mg, INN kobimetinib tbl. 20 mg,  INN obinutuzumab inf. 1000 mg, INN bevacizumab inf. 100 mg, INN pertuzumab inf. 420mg i INN alektinib kapsule 150 mg","Number":"804-4-1-76/21","Status":"Completed","Type":"NegotiatedProcedureWithoutProcurementNotice","BidderCount":"OneBidder","BiddingInvitationType":null,"ContactPersonName":"Amina Pašukanović-Zenunović","ContractCategoryId":47,"ContractCategoryName":"Kupovina","ContractSubcategoryId":null,"ContractSubcategoryName":null,"IsAlternativeOfferAllowed":false,"IsCentralizedProcurement":false,"IsContractRenewable":false,"IsDefenceAndSecurity":false,"IsDocumentationOnline":false,"IsGpa":false,"IsInternationalAnnouncement":false,"LotOfferType":"MultipleLots","MasterAgreementStatus":null,"MasterAgreementSubType":null,"NegotiatedProcedureAnnouncementOption":"AwardNoticeAnnouncement","NegotiatedSuppliersCount":null,"NoDivisonIntoLotsExplanation":null,"OffersSubmissionExplanation":null,"PhaseNumber":null,"PiNoticeId":null,"PiNoticeName":null,"PreviousProcedureId":null,"PreviousProcedureName":null,"QsNoticeId":null,"QsNoticeName":null,"ReasonsForNegotiatedProcedure":"zbog suštinskih i dokazivih tehničkih razloga koji se odnose na zaštitu ekskluzivnih prava, nabavka navedenih lijekova može se obezbijediti samo od dobavljača Roche d.o.o. Roche Ltd.","RegulationQuoteId":75,"RegulationQuoteName":"Član 21. Stav (1) Tačka c)","LastUpdated":"2023-05-08T07:35:07.0106414Z"}]}